/**
 * AI in Clinical Decision Support Compliance Pack
 *
 * 21 U.S.C. §360(h) — FDA SaMD definition
 * 21 U.S.C. §360j(o) — 21st Century Cures Act §3060 CDS exclusion
 * FDA September 2022 Clinical Decision Support Guidance
 * FDA AI/ML Action Plan (2021) and AI/ML SaMD Action Plan
 * TX SB 1188 (effective Sept. 1, 2025) + TX HB 149 / TRAIGA (effective Jan. 1, 2026)
 * CA SB 1120 (effective Jan. 1, 2025)
 *
 * Enforces 5 of 7 rules from rules.md:
 *   BLOCK: AICDS-001 (SaMD FDA authorization), AICDS-003 (physician review checkpoint),
 *          AICDS-005 (direct-to-patient without clinician review)
 *   WARN:  AICDS-002 (CDS transparency), AICDS-004 (algorithm version tracking)
 *   INFO:  AICDS-006 (performance monitoring)
 *   SKIP:  AICDS-007 — human-attestation (bias assessment requires review of validation data)
 *
 * @connexum/ai-governance | Kai (CXNI-005) | 2026-05-24
 */
import { CompliancePack } from './index';
import { CategoryClassifiers } from '../classification/pack-driven-classifier';
export declare const AI_CDS_CATEGORY_CLASSIFIERS: CategoryClassifiers;
export declare const AI_CDS_PACK: CompliancePack & {
    categoryClassifiers: CategoryClassifiers;
};
//# sourceMappingURL=ai-clinical-decision-support.d.ts.map